National Comprehensive Cancer Network



Educational Events & Programs

NCCN Guidelines Update Webinar Series™: Colorectal Cancers

Register now!

Program Overview:
This 60-minute webinar, which will be offered on four (4) different occasions, is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Colorectal Cancer. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This webinar will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Presenter:
Leonard Saltz, MD
Memorial Sloan-Kettering Cancer Center

Register now for one of the following sessions (each webinar provides the same content):

  • Monday, October 15, 2012 • 1:00 – 2:00 PM EDT
  • Thursday, October 25, 2012 • 2:00 – 3:00 PM EDT
  • Wednesday, October 31, 2012 • 12:30 – 1:30 PM EDT

Educational Objectives:

  • Describe recent advances in the management of patients with colorectal cancer
  • Outline the implications of recent research and practice changes to the clinical algorithms for patients with colorectal cancer

Intended Audience:
This educational program is designed to meet the educational needs of oncologists, nurses, and other health care professionals who manage patients with cancer.

Accreditation:
This webinar series is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided for all sessions. Although multiple sessions are offered, CME/CE credits will only be awarded once per attendee. View complete accreditation details.

Fee Information:
There is no fee for this educational activity for registrants.

Supporters:
This activity is supported by educational grants from Bayer Healthcare Pharmaceuticals Inc.; Genentech; and Veridex, LLC.

 

Register now for the 2012 NCCN Guidelines Update Webinar Series™: Colorectal Cancers